Aptose Biosciences Inc, formerly Lorus Therapeutics Inc., is a life sciences company. The Company is focused on the discovery, research and development of effective anticancer therapies with a safety profile. The Company has worked to establish a diverse anticancer product pipeline, with products in various stages of development ranging from pre-clinical to a completed Phase I clinical trial. Intellectual property portfolio supports its diverse product pipeline.